Association of malaria parasite population structure, HLA, and immunological antagonism.

Host-parasite coevolution has been likened to a molecular arms race, with particular parasite genes evolving to evade specific host defenses. Study of the variants of an antigenic epitope of Plasmodium falciparum that induces a cytotoxic T cell response supports this view. In African children with malaria, the variants present are influenced by the presence of a human leukocyte antigen (HLA) type that restricts the immune response to this epitope. The distribution of parasite variants may be further influenced by the ability of cohabiting parasite strains to facilitate each other's survival by down-regulating cellular immune responses, using altered peptide ligand antagonism.

[1]  A. Hill,et al.  Recombinant vaccinia viruses for the characterization of Plasmodium falciparum-specific cytotoxic T lymphocytes: recognition of processed antigen despite limited re-stimulation efficacy. , 1997, International immunology.

[2]  A. Hill,et al.  Precursor frequency analysis of cytotoxic T lymphocytes to pre-erythrocytic antigens of Plasmodium falciparum in West Africa. , 1997, Journal of immunology.

[3]  A. McMichael,et al.  An HLA‐B35‐restricted epitope modified at an anchor residue results in an antagonist peptide , 1996, European journal of immunology.

[4]  R. Paru,et al.  Mating patterns in malaria parasite populations of Papua New Guinea. , 1995, Science.

[5]  M. Davenport,et al.  Antagonists or altruists: do viral mutants modulate T-cell responses? , 1995, Immunology today.

[6]  P. Klenerman,et al.  The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus , 1995, European journal of immunology.

[7]  M. Aidoo,et al.  Induction of peptide‐specific primary cytotoxic T lymphocyte responses from human peripheral blood , 1995, European journal of immunology.

[8]  A. Hill,et al.  Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria , 1995, The Lancet.

[9]  H C Thomas,et al.  Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. , 1995, The New England journal of medicine.

[10]  J. Charlwood,et al.  Random mating in a natural population of the malaria parasite Plasmodium falciparum , 1994, Parasitology.

[11]  S. Gupta,et al.  Antigenic diversity and the transmission dynamics of Plasmodium falciparum. , 1994, Science.

[12]  M. Aidoo,et al.  An HLA-based approach to the design of a CTL-inducing vaccine against Plasmodium falciparum. , 1994, Research in immunology.

[13]  H. Grey,et al.  The inhibition of different T cell lines specific for the same antigen with TCR antagonist peptides. , 1993, Journal of immunology.

[14]  Timothy E. Elliott,et al.  A quantitative assay of peptide‐dependent class I assembly , 1991, European journal of immunology.

[15]  Andrew J. McMichael,et al.  Common West African HLA antigens are associated with protection from severe malaria , 1991, Nature.

[16]  V. Nussenzweig,et al.  Plasmodium falciparum: restricted polymorphism of T cell epitopes of the circumsporozoite protein in Brazil. , 1990, Experimental parasitology.

[17]  C. Newbold,et al.  Wild isolates of Plasmodium falciparum show extensive polymorphism in T cell epitopes of the circumsporozoite protein. , 1989, Molecular and biochemical parasitology.

[18]  V. Nussenzweig,et al.  Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria , 1989, Nature.

[19]  T. Burkot,et al.  Genetic analysis of the human malaria parasite Plasmodium falciparum. , 1987, Science.